Literature DB >> 20709562

Closure of persisting air leaks in patients with severe pleural empyema--use of endoscopic one-way endobronchial valve.

Michael Schweigert1, Dietmar Kraus, Joachim H Ficker, Hubert J Stein.   

Abstract

Parapneumonic pleural empyema is a critical illness with mortality up to 20%. Patients often have severe comorbidity and are not always suitable for major thoracic surgery. Peripheral bronchopleural fistula adds further difficulty. This may result in a situation where recovery is impossible. Therefore, we developed a combination of minimally invasive surgical debridement and closure of the air leak with a bronchoscopic one-way endobronchial valve. Thus far, two patients received the combined treatment. Both patients suffered from a pleural empyema and because of severe comorbidity were not fit for major thoracic surgery. First, minimally invasive surgical debridement of the pleural cavity was performed. In both patients, a persisting peripheral bronchopleural fistula occurred. Via bronchoscopy the leak could be localized in both cases in the lower lobe segment 8. In each case, we implanted an endobronchial one-way valve designed for the treatment of lung emphysema. After the bronchoscopic valve implantation, the leakage ceased in both cases and healing of the pleural empyema was achieved. The valves were subsequently removed via bronchoscopy. Successful closure of peripheral air leaks in patients with pleural empyema using an endoscopic one-way valve is feasible. It is a treatment option in patients who are not fit for major thoracic surgery.
Copyright © 2010 European Association for Cardio-Thoracic Surgery. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20709562     DOI: 10.1016/j.ejcts.2010.07.004

Source DB:  PubMed          Journal:  Eur J Cardiothorac Surg        ISSN: 1010-7940            Impact factor:   4.191


  9 in total

1.  Successful treatment of a life-threatening air leakage, complicating severe abdominal sepsis, with a one-way endobronchial valve.

Authors:  Pierre-Yves Brichon; Camille Poquet; Catherine Arvieux; Christophe Pison
Journal:  Interact Cardiovasc Thorac Surg       Date:  2012-07-03

2.  Endobronchial valve treatment of destructive multidrug-resistant tuberculosis.

Authors:  A Levin; S Sklyuev; I Felker; E Tceymach; D Krasnov
Journal:  Int J Tuberc Lung Dis       Date:  2016-11       Impact factor: 2.373

3.  Endobronchial valves in the management of broncho-pleural and alveolo-pleural fistulae.

Authors:  Y El-Sameed; A Waness; I Al Shamsi; A C Mehta
Journal:  Lung       Date:  2012-01-14       Impact factor: 2.584

4.  Intrathoracic negative pressure therapy and/or endobronchial valve for pleural empyema minimal invasive management: case series of thirteen patients and review of the literature.

Authors:  Siarhei Panko; Denis Vakulich; Aliaksandr Karpitski; Henadzi Zhurbenka; Andrej Shestiuk; Rostislav Boufalik; Aliaksandr Ihnatsiuk
Journal:  Wideochir Inne Tech Maloinwazyjne       Date:  2020-02-24       Impact factor: 1.195

Review 5.  The past, current and future of diagnosis and management of pleural disease.

Authors:  Jason Akulian; David Feller-Kopman
Journal:  J Thorac Dis       Date:  2015-12       Impact factor: 2.895

6.  Bronchoscopic treatment of complex persistent air leaks with endobronchial one-way valves.

Authors:  Alfonso Fiorelli; Saveria Costanzo; Emanuele Carelli; Emilio Di Costanzo; Mario Santini
Journal:  Gen Thorac Cardiovasc Surg       Date:  2014-09-23

Review 7.  Endobronchial valves in treatment of persistent air leaks: a systematic review of clinical evidence.

Authors:  Ioannis D Gkegkes; Sarantis Mourtarakos; Ioannis Gakidis
Journal:  Med Sci Monit       Date:  2015-02-09

Review 8.  Endobronchial one-way valves for treatment of persistent air leaks: a systematic review.

Authors:  Mei Ding; Ya-Dong Gao; Xian-Tao Zeng; Yi Guo; Jiong Yang
Journal:  Respir Res       Date:  2017-11-06

9.  The efficacy of endobronchial valves for the treatment of bronchopleural fistula: a single-arm clinical trial.

Authors:  Xinmiao Song; Ye Gu; Hao Wang; Li Zhang
Journal:  J Thorac Dis       Date:  2022-03       Impact factor: 2.895

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.